Skip to content

Patient voice — retinoblastoma

This layer synthesizes public, aggregate evidence from survivors and caregivers. It does not treat testimonials as efficacy evidence and does not create individual dossiers.

Files

File Contents
organizations.md verified organizations and support networks
themes.md themes supported by at least two independent sources
sources.md annotated research and public-web sources, plus coverage limits

Method — 2026-09-01

Live PubMed searches combined retinoblastoma with parent, caregiver, psychosocial, quality of life, visual function, enucleation, prosthesis, diagnostic delay, referral, and survivor. Every PMID used here was returned and fetched through PubMed E-utilities in this build.

Organization searches covered global, UK, Canada and India. Each included organization site was fetched or search-result-opened on 2026-09-01. A live page establishes current web presence and stated services, not independent proof of reach or quality.

Ethics applied

  1. Public sources only; no closed groups, private forums, messages or member databases.
  2. No private individual is named, quoted or profiled.
  3. Public stories are used only at hub level to identify domains of experience.
  4. No quotation is reproduced; this is stricter than the 15-word maximum.
  5. A theme requires at least two independent sources.
  6. Caregiver report and survivor report remain separate when they differ.
  7. Qualitative studies identify mechanisms and priorities, not prevalence.
  8. Organization claims describe their stated mission/services, not treatment outcomes.
  9. The terms heritable and non-heritable are preserved because lifelong cancer uncertainty differs materially.
  10. Child safety and privacy outweigh narrative completeness.

Interpretation boundaries

  • Retinoblastoma is diagnosed before many children can self-report; early-course evidence is therefore caregiver-heavy.
  • Enucleation, bilateral visual loss, globe salvage and useful vision are different experiences.
  • Culture, language, travel, income, treatment availability and survival probability shape what families report.
  • School-age and adult-survivor findings cannot be projected backward to toddlers in treatment.
  • Parent–child rating disagreement is evidence about perspective, not proof that one reporter is correct.

Coverage limits

The published qualitative base located here is small and English-indexed. The strongest direct parent study is from Ethiopia; the strongest survivor QOL studies are from specialist cohorts. Public organizations with stable English websites are overrepresented. Latin America, Francophone Africa, the Middle East, East Asia and non-English survivor-led sources need dedicated multilingual work.